• 3 years ago
Rappler's Lian Buan gives the highlights of the Senate blue ribbon committee hearing Tuesday, September 21, where senators continue to dig more against questionable government contacts between PS-DBM and Pharmally Pharmaceuticals.

Category

🗞
News

Recommended